160 related articles for article (PubMed ID: 33497469)
21. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
Int J Cancer; 1999 Mar; 80(5):646-51. PubMed ID: 10048960
[TBL] [Abstract][Full Text] [Related]
23. Childhood melanoma in Europe since 1978: a population-based survival study.
Conti EM; Cercato MC; Gatta G; Ramazzotti V; Roscioni S;
Eur J Cancer; 2001 Apr; 37(6):780-4. PubMed ID: 11311654
[TBL] [Abstract][Full Text] [Related]
24. Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.
Geller AC; Clapp RW; Sober AJ; Gonsalves L; Mueller L; Christiansen CL; Shaikh W; Miller DR
J Clin Oncol; 2013 Nov; 31(33):4172-8. PubMed ID: 24043747
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma.
Claeson M; Baade P; Brown S; Soyer HP; Smithers BM; Green AC; Whiteman DC; Khosrotehrani K
Br J Dermatol; 2020 Apr; 182(4):927-931. PubMed ID: 31562769
[TBL] [Abstract][Full Text] [Related]
26. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
27. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
29. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
30. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
[TBL] [Abstract][Full Text] [Related]
31. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
32. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
33. Melanoma epidemiology of Austria reveals gender-related differences.
Duschek N; Skvara H; Kittler H; Delir G; Fink A; Pinkowicz A; Waldhör T
Eur J Dermatol; 2013; 23(6):872-8. PubMed ID: 24184485
[TBL] [Abstract][Full Text] [Related]
34. Incidence trends and survival of skin melanoma and squamous cell carcinoma in Cluj County, Romania.
Şuteu O; Blaga ML; Nicula F; Şuteu P; Coza O; Achimaş-Cadariu P; Coza D
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S176-S182. PubMed ID: 28914690
[TBL] [Abstract][Full Text] [Related]
35. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.
Padrik P; Valter A; Valter E; Baburin A; Innos K
Acta Oncol; 2017 Jan; 56(1):52-58. PubMed ID: 27796149
[TBL] [Abstract][Full Text] [Related]
36. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
37. Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study.
Galceran J; Uhry Z; Marcos-Gragera R; Borràs J;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S77-S84. PubMed ID: 28005609
[TBL] [Abstract][Full Text] [Related]
38. Pediatric patients with cutaneous melanoma: A European study.
Brecht IB; De Paoli A; Bisogno G; Orbach D; Schneider DT; Leiter U; Offenmueller S; Cecchetto G; Godzinski J; Bien E; Stachowicz-Stencel T; Ben-Ami T; Chiaravalli S; Maurichi A; De Salvo GL; Sorbara S; Bodemer C; Garbe C; Reguerre Y; Ferrari A
Pediatr Blood Cancer; 2018 Jun; 65(6):e26974. PubMed ID: 29350487
[TBL] [Abstract][Full Text] [Related]
39. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
Downing A; Newton-Bishop JA; Forman D
Br J Cancer; 2006 Jul; 95(1):91-5. PubMed ID: 16755289
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
